Quality of life in dystonia and multiple sclerosis
| Citation | Class | n | Age, mean >(years) | Mean duration of disease (years) | HRQoL tool | Follow up >(months) | HRQoL improvements |
|---|---|---|---|---|---|---|---|
| *p<0.05. | |||||||
| NA, not available; PDQ3SI, Parkinson’s Disease Questionnaire Summary Index; SF-36, Medical Outcomes Study 36-item Short-Form General Health Survey. | |||||||
| Dystonia | |||||||
| Vidailhet et al75 | 2 | 22 | 30 (14–54) | 18 (4–37) | SF-36 | 12 | General health 16%* |
| Physical function 21%* | |||||||
| Vitality 10%* | |||||||
| Kiss et al77 | 4 | 2 | 63 | 14 | SF-36 | 12 | SF-36 total score 41.9 |
| 48 | 5 | 6 | SF-36 total score 30.3 | ||||
| Kupsch et al76 | 3 | 5 | 37 (13–56) | 11.8 (2–32) | mPDQ-39 | 3-12 | PDQ-39 65%* |
| EuroQol 1 | EuroQol 1 56%* | ||||||
| EuroQol 2 | EuroQol 2 400%* | ||||||
| Multiple sclerosis | |||||||
| Berk et al59 | 3 | 12 | 34.5 (28–42) | NA | SF-36 | 12 | No change in SF-36 total score or subscores. |